Rapidly in situ forming polyphosphoester-based hydrogels for injectable drug delivery carriersElectronic supplementary information (ESI) available: Detailed information on the experimental details, Scheme S1-S2, Table S1, and Fig. S1-S5. See DOI: 10.1039/c2sm25274k
In situ forming hydrogels allow the modulation of physicochemical properties and are providing new opportunities for biomedical applications. Here, the preparation and characterization of a series of rapidly in situ forming and pH-responsive hydrogels with different crosslinking degrees are reported...
Saved in:
Main Authors | , , |
---|---|
Format | Journal Article |
Language | English |
Published |
16.05.2012
|
Online Access | Get full text |
Cover
Loading…
Summary: | In situ
forming hydrogels allow the modulation of physicochemical properties and are providing new opportunities for biomedical applications. Here, the preparation and characterization of a series of rapidly
in situ
forming and pH-responsive hydrogels with different crosslinking degrees are reported, which were achieved by accelerated free radical copolymerization of polyphosphoester-based macrocrosslinker and 2-(dimethylamino)ethyl methacrylate (DMAEMA) monomer. The hydrogel formation can be completed very quickly under mild conditions, ranging from several to tens of minutes with varying concentrations of components. The polyphosphoester-based macrocrosslinker was synthesized
via
a combination of ring-opening polymerization and post-polymerization modification, and it was characterized by
1
H NMR,
31
P NMR, and GPC measurements. The sol-gel transition was monitored by dynamic time sweep rheological analysis. Moreover, the swelling kinetics, interior morphology, pH-responsive property,
in vitro
cytotoxicity and drug release of these hydrogels were characterized. The results indicate that these hydrogels show great potential as injectable drug delivery system.
Fabrication of novel rapidly
in situ
forming polyphosphoester-based hydrogels with adjustable gelation time for injectable drug delivery carriers. |
---|---|
Bibliography: | Electronic supplementary information (ESI) available: Detailed information on the experimental details, Scheme S1-S2, Table S1, and Fig. S1-S5. See DOI 10.1039/c2sm25274k |
ISSN: | 1744-683X 1744-6848 |
DOI: | 10.1039/c2sm25274k |